Back

All diabetic patients should be treated with SGLT2 inhibitors.

29 August 2022 (09:06 - 09:24)
Organised by:
Congress Presentation Part of: Meet the Experts: how to lower cardiovascular disease risk in patients with diabetes Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Associate Professor Linda Mellbin

Karolinska University Hospital, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail
Assessment of risk in diabetic patients.
Professor F. Cosentino (Stockholm, SE)
Slides Video
Presentation thumbnail
All diabetic patients should be treated with GLP1 and/or GIP agonists.
Professor A. Cahn (Jerusalem, IL)
Slides Video
Presentation thumbnail
All diabetic patients should be treated with metformin.
Professor H. Drexel (Feldkirch, AT)
Slides Video
Presentation thumbnail
Putting it all together: how to lower cardiovascular disease risk in patients with diabetes.
Professor N. Marx (Aachen, DE)
Slides Video

Access the full session

Session thumbnail
Meet the Experts: how to lower cardiovascular disease risk in patients with diabetes
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 09:06 CET
You may be interested in
thumbnail
Webinar
Cardiovascular disease in patients with diabetes and chronic kidney disease. ESC 2023 Clinical Practice Guidelines - Webinar Series
thumbnail
Webinar
Risk factor management in diabetes. ESC 2023 Clinical Practice Guidelines - Webinar Series
thumbnail
Webinar
Chronic kidney disease: a modifiable cardiovascular risk factor in patients with type 2 diabetes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources